Study to evaluate the safety of SAR650984 (isatuximab) in R/R MM pts
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Sanofi US
Start Date
January 10, 2017
End Date
May 8, 2019
Administered By
Duke Cancer Institute
Awarded By
Sanofi US
Start Date
January 10, 2017
End Date
May 8, 2019